Pharmacogenetics of antipsychotic treatment: lessons learned from clozapine

This publication has 92 references indexed in Scilit:

• Application of pharmacogenetics to psychotic disorders: the first consensus conference1Participants (in alphabetical order): A. Breier, L.E. DeLisi, F. Henn, W. Kalow, R. Kerwin, J. Kurth, B. Lerer, A. Malhotra, M. Masellis, H.J. Möller, V. Ozdemir, J. Peuskens, N.R. Schooler, V.M. Steen.12Conference organizers: M. Rietschel, J.L. Kennedy, F. Macciardi, H.Y. Meltzer.23Section Chairs: J.M. Kane and H.Y. Meltzer, J.L. Kennedy and S. Marder, F. Macciardi and M.M. Nöthen, A.G. Awad.3
  Schizophrenia Research, 1999
• The Clinical Use of Plasma Clozapine Levels
  Australian & New Zealand Journal of Psychiatry, 1998
• Linkage and association
  Genetic Epidemiology, 1998
• Pharmacokinetics of Clozapine and Risperidone
  Journal of Clinical Psychopharmacology, 1996
• Association between clozapine response and allelic variation in the 5-HT2C receptor gene
  NeuroReport, 1995
• Deriving the therapeutic concentrations for clozapine and haloperidol: The apparent dissociation constant of a neuroleptic at the dopamine D2 or D4 receptor varies with the affinity of the competing radioligand
  European Journal of Pharmacology: Molecular Pharmacology, 1995
• Candidate genes in psychiatry: An epidemiological perspective
  American Journal of Medical Genetics, 1993
• Dopamine D4 receptor subtypes and response to clozapine
  The Lancet, 1993
• Clinical pharmacokinetics of clozapine in chronic schizophrenic patients
  European Journal of Clinical Pharmacology, 1988
• Meta-analysis in clinical trials
  Controlled Clinical Trials, 1986